SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-22-008336
Filing Date
2022-06-14
Accepted
2022-06-14 17:05:56
Documents
15
Period of Report
2022-06-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbsv_8k.htm   iXBRL 8-K 22815
2 PRESS RELEASE pbsv_ex991.htm EX-99.1 6003
  Complete submission text file 0001654954-22-008336.txt   141092

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pbsv-20220614.xsd EX-101.SCH 5830
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbsv-20220614_lab.xml EX-101.LAB 12648
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbsv-20220614_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbsv-20220614_pre.xml EX-101.PRE 7937
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbsv-20220614_def.xml EX-101.DEF 2103
9 EXTRACTED XBRL INSTANCE DOCUMENT pbsv_8k_htm.xml XML 3136
Mailing Address INDUSTRIAL ZONE STREET 1 LOT 14 DORADO PR 00646
Business Address INDUSTRIAL ZONE STREET 1 LOT 14 DORADO PR 00646 787-278-2709
Pharma-Bio Serv, Inc. (Filer) CIK: 0001304161 (see all company filings)

IRS No.: 200653570 | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-50956 | Film No.: 221015646
SIC: 8742 Services-Management Consulting Services